Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-10-10 Purchase | 2020-10-14 4:05 pm | AKCEA THERAPEUTICS INC. | AKCA | IONIS PHARMACEUTICALS INC 10% Owner | 21,237,715 | $18.15 | $385,464,527 | 98,322,397 (Indirect) | View |
| 2020-09-22 Sale | 2020-09-24 4:25 pm | AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel | 319 | $18.12 | $5,780 | 26,532 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:21 pm | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 720 | $18.12 | $13,046 | 52,012 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:19 pm | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 8,709 | $18.12 | $157,807 | 242,978 (Direct) | View |
| 2020-07-17 Sale | 2020-07-20 5:18 pm | AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel | 263 | $12.5 | $3,288 | 26,851 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-10-12 Equity Swap | 2020-10-13 4:04 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | PRICE MICHAEL DENNIS Chief Financial Officer | 50,000 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 4:02 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel | 26,532 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:59 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 52,012 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:58 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Howarth Alex G. Chief Operating Officer | 66,800 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:56 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer | 37,500 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:54 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 242,978 | $18.15 | 0 (Direct) | View |
| 2020-08-31 Option Award | 2020-09-02 4:20 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 1,104 | $14.4 | 251,687 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-10 5:31 pm | N/A 2030-07-08 | AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer | 287,500 | $0 | 287,500 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-19 5:41 pm | N/A 2030-05-17 | AKCEA THERAPEUTICS INC. | AKCA | PRICE MICHAEL DENNIS Chief Financial Officer | 350,000 | $0 | 350,000 (Direct) | View |